Topical KD7040

· Kalypsys, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical KD7040, covering 2008-07-22 to 2008-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]